XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity and Share-Based Compensation
 3 Months Ended
Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stockholders' Equity and Share-Based Compensation
Note 8: Stockholders' Equity and Share-Based Compensation
Share issuances and repurchases
The Company treats shares withheld for tax purposes on behalf of our employees in connection with the vesting of time-based and performance restricted stock units as common stock repurchases because they reduce the number of shares that would have been issued upon vesting. During the thirteen weeks ended April 30, 2023 and May 1, 2022, respectively, we withheld 0.02 and 0.03 shares of common stock to satisfy $0.6 and $1.2 of employees’ tax obligations, respectively.
On March 27, 2023, our Board of Directors approved a share repurchase program with an authorization limit of $100.0, expiring at the end of fiscal 2023. During the thirteen weeks ended April 30, 2023, the Company repurchased the full amount of $100.0 authorized under this program totaling 2.86 million shares at an average of $34.98 per share.
On April 19, 2023, our Board of Directors approved a share repurchase program with an authorization limit of $200.0, expiring at the end of fiscal 2023. During the thirteen weeks ended April 30, 2023, the Company repurchased 0.75 million shares at an average of $34.18 per share. The remaining dollar value of shares that may be repurchased under the plan is $174.5.
Share-based compensation
Our compensation expense related to share-based compensation was as follows:
Thirteen Weeks Ended
April 30, 2023May 1, 2022
General and administrative expenses$6.7 $3.6 
Our share-based compensation award activity during the thirteen weeks ended April 30, 2023 was as follows:
Options Restricted
Stock Units 		Total
Outstanding at January 29, 20230.981.892.87
Granted0.080.260.34
RSU vestings n/a (0.06)(0.06)
Forfeited—(0.02)(0.02)
Outstanding at April 30, 20231.062.073.13
Remaining unrecognized compensation expense$6.6 $46.6 $53.2 
The fair value of our time-based and performance-based restricted stock units is based on our closing stock price on the date of grant. The grant date fair value of stock options was determined using the Black-Scholes option valuation model. The grant date fair value of performance-based awards with market conditions was determined using the Monte Carlo valuation model. The unrecognized expense will all be substantially recognized by the end of fiscal 2025.
During the thirteen weeks ended April 30, 2023, the Company granted certain options, time-based, performance-based, and market-based restricted stock units to employees and directors of the Company. These grants vest over a range of one year to 5 years. Certain of the market-based restricted stock units can vest earlier if the targets are achieved prior to that time. As a result, the requisite service period for such grants was determined to be less than the explicit service period.During the thirteen weeks ended April 30, 2023 and May 1, 2022, excess tax expense (benefit) of $0.4 and $(0.1), respectively, were recognized in the “Provision for income taxes” in the Consolidated Statement of Comprehensive Income and classified as a source in operating activities in the Consolidated Statement of Cash Flows.